1. Anti-infection Cytoskeleton Cell Cycle/DNA Damage PI3K/Akt/mTOR Stem Cell/Wnt JAK/STAT Signaling Immunology/Inflammation Apoptosis GPCR/G Protein
  2. Bacterial Fungal PAK Akt STAT PD-1/PD-L1 Apoptosis CCR
  3. Globulol

Globulol is a terpenoid metabolite and Antimicrobial agent. Globulol can be isolated from Alpinia oxyphylla Miq. Globulol binds to PAK4, reduces the expression level of PAK4 in cancer cells, decreases the phosphorylation of AKT, and downregulates the expressions of STAT3, phosphorylated STAT3, and PD-L1. Globulol promotes the secretion of CCL4 by cancer cells. Globulol reduces the viability and proliferation ability of cancer cells, induces G0/G1 cell cycle arrest and Apoptosis in cancer cells, and inhibits cancer cell migration and the integrity of 3D tumor spheres. Globulol enhances the relevant effects of anti-PD-1 agents in the cancer cell microenvironment. Globulol exhibits anticancer activity against liver cancer. Globulol inhibits the mycelial growth of phytopathogenic fungi and the growth of phytopathogenic bacteria. Globulol can be used in studies related to hepatocellular carcinoma.

For research use only. We do not sell to patients.

Globulol

Globulol Chemical Structure

CAS No. : 489-41-8

Size Price Stock Quantity
1 mg In-stock
5 mg In-stock
10 mg In-stock
50 mg   Get quote  
100 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products

View All PAK Isoform Specific Products:

View All Akt Isoform Specific Products:

View All STAT Isoform Specific Products:

View All CCR Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Globulol is a terpenoid metabolite and Antimicrobial agent. Globulol can be isolated from Alpinia oxyphylla Miq. Globulol binds to PAK4, reduces the expression level of PAK4 in cancer cells, decreases the phosphorylation of AKT, and downregulates the expressions of STAT3, phosphorylated STAT3, and PD-L1. Globulol promotes the secretion of CCL4 by cancer cells. Globulol reduces the viability and proliferation ability of cancer cells, induces G0/G1 cell cycle arrest and Apoptosis in cancer cells, and inhibits cancer cell migration and the integrity of 3D tumor spheres. Globulol enhances the relevant effects of anti-PD-1 agents in the cancer cell microenvironment. Globulol exhibits anticancer activity against liver cancer. Globulol inhibits the mycelial growth of phytopathogenic fungi and the growth of phytopathogenic bacteria. Globulol can be used in studies related to hepatocellular carcinoma[1][2].

IC50 & Target[1]

PAK4

 

STAT3

 

In Vitro

Globulol (0-320 μM; 24 h) reduces the viability of Huh1 and Huh7 hepatocellular carcinoma cells in a concentration-dependent manner, with IC50 values of 136.6 μM and 141.5 μM, respectively[1].
Globulol (40-120 μM; 24 h) induces G0/G1 cell cycle arrest in Huh1 and Huh7 hepatocellular carcinoma cells[1].
Globulol (40-120 μM) induces apoptosis in Huh1 and Huh7 hepatocellular carcinoma cells in a dose-dependent manner[1].
Globulol (40-120 μM; 12 h) inhibits the migratory capacity of Huh1 and Huh7 hepatocellular carcinoma cells in 3D tumor spheroid models[1].
Globulol (80 μM) enhances the migratory capacity of activated CD8+ T cells toward Huh1 and Huh7 hepatocellular carcinoma cells by upregulating the expression of CCL4 during a 24-hour co-cultivation process[1].
Globulol (80 μM; 24 h) enhances CD8+ T cell-mediated cytotoxicity against 3D spheroids of Huh7 hepatocellular carcinoma cells during a 24-hour co-culture process[1].
Globulol (40-120 μM) inhibits the PAK4-pAKT-STAT3 pathway and reduces the expression of PD-L1 protein in wild-type, PAK4-overexpressing and PAK4-knockdown Huh7 hepatocellular carcinoma cells[1].
Globulol inhibits the growth of Xanthomonas vesicatoria and Bacillus subtilis, with an IC50 of 158.0 μg mL−1 against the former and 737.2 μg mL−1 against the latter[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: Huh1, Huh7, LX-2 human hepatic stellate cells
Concentration: 0-320 μM (Huh1, Huh7); 30-160 μM (LX-2)
Incubation Time: 24 h
Result: Significantly reduced the viability of Huh1 and Huh7 cells in a concentration-dependent manner, with IC50 values of 136.6 μM (Huh1) and 141.5 μM (Huh7) (P < 0.001).
Caused no notable viability changes in LX-2 cells at concentrations ranging from 30 to 160 μM (P > 0.05).

Cell Cycle Analysis[1]

Cell Line: Huh1, Huh7 hepatocellular carcinoma cells
Concentration: 40-120 μM
Incubation Time: 24 h
Result: Caused a substantial, dose-dependent increase in the G0/G1 phase fraction of both Huh1 and Huh7 cells compared to controls (P < 0.001).

Cell Migration Assay [1]

Cell Line: Huh1, Huh7 hepatocellular carcinoma cells
Concentration: 40-120 μM
Incubation Time: 12 h
Result: Reduced the density of migrating cells from tumor spheroids in a dose-dependent manner.
Made tumor spheroid boundaries well-defined with few migrating cells at 120 μM.
Significantly reduced the relative invasion area in both Huh1 (P < 0.01) and Huh7 (P < 0.001) cells compared to controls.

Western Blot Analysis[1]

Cell Line: Huh7 hepatocellular carcinoma cells (wild-type, PAK4-overexpressing, and PAK4-knockdown)
Concentration: 40-120 μM (wild-type cells); 120 μM (PAK4-overexpressing and PAK4-knockdown cells)
Incubation Time: A certain period of time
Result: Dose-dependently reduced protein levels of PAK4, p-AKT (Ser473), STAT3, p-STAT3 (Y705), and PD-L1 in wild-type Huh7 cells, with no notable effect on total AKT levels.
Reduced protein levels of PAK4, p-AKT (Ser473), STAT3, p-STAT3 (Y705), and PD-L1 in PAK4-overexpressing Huh7 cells.
Further reduced protein levels of PAK4, STAT3, p-STAT3 (Y705), and PD-L1 in PAK4-knockdown Huh7 cells compared to the knockdown-only group.
Molecular Weight

222.37

Formula

C15H26O

CAS No.
Appearance

Solid

Color

White to off-white

SMILES

CC1([C@@]2([H])[C@@]3([H])[C@](CC[C@H]3C)([H])[C@](O)(CC[C@]21[H])C)C

Structure Classification
Initial Source
Shipping

Room temperature in continental US; may vary elsewhere.

Storage

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Globulol
Cat. No.:
HY-N8389
Quantity:
MCE Japan Authorized Agent: